Trials / Unknown
UnknownNCT01315262
On Demand Versus Daily Sildenafil for Patients Undergoing Radical Prostatectomy
On Demand Versus Daily Sildenafil for Patients Undergoing Bilateral Nerve Sparing Radical Prostatectomy: a Randomized, Open Label, Parallel Group Trial
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Università Vita-Salute San Raffaele · Academic / Other
- Sex
- Male
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Viagra (Sildenafil citrate) is an orally active selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5) which is used for the treatment of erectile dysfunction (ED). Objectives: * To test the efficacy of Viagra 100mg on demand vs. Viagra 100mg daily (taken either at bedtime or 1 hour prior to sexual intercourse) in restoring erectile function following radical prostatectomy. * To test the safety and tolerability of Viagra 100 mg on demand vs. Viagra 100 mg daily after radical prostatectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sildenafil | 1:1 Viagra 100 mg daily (taken either at bedtime - if sexual intercourse is not expected - or 1 hour prior to sexual intercourse, no more than one 100 mg dose of sildenafil per day) vs. Viagra 100mg OD (i.e. one hour prior to sexual intercourse) |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-09-01
- Completion
- 2012-12-01
- First posted
- 2011-03-15
- Last updated
- 2011-03-29
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01315262. Inclusion in this directory is not an endorsement.